United States Antimony Corporation’s UAMY share price has dipped by 18.90%, which has investors questioning if this is right time to buy.

Catalyst synthesis is the process of fabricating catalytic materials. It aims to optimize factors such as the catalyst activity, selectivity, stability and cost. The reactivity of ketenes is ...

Ecovyst Inc. (NYSE: ECVT), a leading integrated and innovative global provider of advanced materials, specialty catalysts, virgin sulfuric acid and sulfuric acid regeneration services ("Ecovyst"), ...

innovates and supplies specialty zeolites used in catalysts that support the production of sustainable fuels, remove nitrogen oxides from diesel engine emissions and that are broadly applied in ...

This marks a major milestone in the company’s growth, as larger quantities of high-performance modified zeolites and catalysts are being produced and commercially delivered to international customers ...

One-pot synthesis of dimethyl carbonate (DMC) from methanol, propylene oxide (PO) and carbon dioxide has been investigated using the basic zeolites as catalysts. Among the zeolites studied, Beta ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 5 undervalued stocks in the Chemicals industry for Friday, May 09, 2025. Let’s take a ...

Apr. 25, 2025 — Researchers found a strategy to create catalysts that make the production of hydrogen for clean fuel more efficient and ... From Beam to Battery: Single-Step Laser Printing ...

CAS Key Laboratory of Low-Carbon Conversion Science and Engineering, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, P. R. China University of Chinese Academy of ...

May 9, 2025 — New bismuth-based organic-inorganic hybrid materials show exceptional sensitivity and long-term stability as X-ray detectors, significantly more sensitive than commercial X-ray ...

Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living ...